KRAS

KRAS

KRAS Overview

Molecule Name
GTPase KRas
Synonyms
GTPase Kras,K-Ras 2,Ki-Ras,c-K-ras,c-Ki-ras,KRAS2,RASK2,C-K-RAS,CFC2,K-RAS2A,K-RAS2B,K-RAS4A,K-RAS4B,KI-RAS,KRAS1,KRAS2,NS,NS3,RASK2,KRAS
Drug Development Progress
Drugs in Clinical Trials40
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,KRAS Proto-Oncogene, GTPase,K-Ras4B,KRAS1,KRAS2,V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog,Kirsten Rat Sarcoma Viral Oncogene Homolog,GTPase KRas,C-Ki-Ras,K-Ras 2,RASK2,Kirsten Rat Sarcoma Viral Proto-Oncogene,Cellular Transforming Proto-Oncogene,Cellular C-Ki-Ras2 Proto-Oncogene,Kras-Enoph1 Fusion Protein,Transforming Protein P21,PR310 C-K-Ras Oncogene,C-Kirsten-Ras Protein,Proto-Oncogene GTPase,K-Ras P21 Protein,KRAS-ENOPH Fusion,Oncogene KRAS2,EC 3.6.5.2,C-Ki-Ras2,'C-K-RAS,C-K-RAS,K-RAS2A,K-RAS2B,K-RAS4A,C-K-Ras,KI-RAS,Ki-Ras,K-Ras,CFC2,RALD,NS3,OES,NS
Background
KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) gene is a proto-oncogene that encodes a small GTPase transductor protein called KRAS. KRAS is also known as Ki-Ras, c-K-ras and c-Ki-ras. Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the regulation of cell proliferation, promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner. RAS is one of the most frequently mutated oncogenes in human cancer but the frequency and distribution of RAS gene mutations are not uniform. In details, mutation of glycine 12 (G12) causes RAS activation by interfering with GAP binding and GAP-stimulated GTP hydrolysis. The reference shows the pathway may as a potential therapy targets.

KRAS Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Pooled mutant-KRAS peptide vaccine (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)Phase 2 ClinicalSidney Kimmel Comprehensive Cancer Center
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Pancreatic Neoplasms
Details
KRAS Neoantigen Nanovaccine (The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School)Phase 2 ClinicalThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Colorectal Neoplasms; Pancreatic Neoplasms
Details
HBW-012462HBW-012462Phase 2 ClinicalHyperway Pharmaceutical Co Ltd
Solid tumours
Details
JAB-23E73JAB-23E73Phase 2 ClinicalJacobio Pharmaceuticals Group Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
ZG-2001ZG2001; ZG-2001Phase 2 ClinicalSuzhou Zelgen Biopharmaceuticals Co Ltd
Neoplasms; Solid tumours
Details
ELI-002ELI-002 2P; Amph-CpG-7909; ELI-002; VED-002Phase 2 ClinicalElicio Therapeutics
Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Gallbladder Neoplasms; Neoplasm, Residual; Ovarian Neoplasms; Solid tumours
Details
mDC3/8-KRAS Vaccine (University of Pennsylvania)Phase 1 ClinicalUniversity Of Pennsylvania
Carcinoma, Pancreatic Ductal
Details
small molecule Ras inhibitors (Boehringer Ingelheim/Vanderbilt University)Phase 1 ClinicalBoehringer Ingelheim International Gmbh
Neoplasms
Details
KRAS peptide vaccine (Sidney Kimmel Cancer Center/Bristol-Myers Squibb)Phase 1 ClinicalSidney Kimmel Comprehensive Cancer Center
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Pancreatic Neoplasms
Details
KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences)Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms
Details
HB-700HB700; HB-700Phase 1 ClinicalHookipa Pharma Inc
Colorectal Neoplasms; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms
Details
KST-6051KST-6051Phase 1 ClinicalKestrel Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
Details
TQB-3205TQB-3205; TQB3205Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Neoplasms
Details
PT-0511PT-0511; PT0511Phase 1 ClinicalPAQ Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
TLN-372TLN-372Phase 1 ClinicalTreeline Biosciences Inc
Solid tumours
Details
ASP-5834ASP5834; ASP-5834Phase 1 ClinicalAstellas Pharma Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
Details
AMG-410AMG-410; AMG 410Phase 1 ClinicalAmgen Inc
Colorectal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours
Details
MPD-1MPD-1Phase 1 ClinicalPharosgen Co Ltd
Neoplasms; Solid tumours
Details
KRAS protein modulator (Eli Lilly and Company)Phase 1 ClinicalEli Lilly And Company
Neoplasms
Details
PF-07985045PF-07985045; PF-5045Phase 1 ClinicalPfizer Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
Details
LY-4066434LY-4066434Phase 1 ClinicalLoxo Oncology Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
Details
BGB-53038BGB-53038Phase 1 ClinicalBeOne Medicines Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Solid tumours; Stomach Neoplasms
Details
KRAS Neoantigen mRNA Vaccine(Abogen Biosciences)ABO2102; ABO-2102Phase 1 ClinicalAbogen Biosciences Co Ltd
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms; Solid tumours
Details
PF-07934040PF-4040; PF-07934040Phase 1 ClinicalPfizer Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
Details
ERAS-4001ERAS-4001Phase 1 ClinicalErasca Inc
Solid tumours
Details
BBO-11818BBO-11818Phase 1 ClinicalBridgebio Pharma Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms
Details
ALTA-3263ALTA-3263Phase 1 ClinicalAlterome Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
QTX-3544QTX-3544; QTX3544Phase 1 ClinicalQuanta Therapeutics Inc
Neoplasms; Solid tumours
Details
AN-9025AN-9025; AN9025Phase 1 ClinicalHangzhou Adlai Nortye Biopharma Co Ltd
Adenocarcinoma of Lung; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
BI-3706674BI-3706674; BI3706674; BI 3706674Phase 1 ClinicalC.H. Boehringer Sohn Ag & Co. Kg
Esophageal Neoplasms; Solid tumours; Stomach Neoplasms
Details
YL-17231YL-17231; YL17231; TEB-17231Phase 1 ClinicalYL-Pharma
Neoplasms; Solid tumours
Details
QTX-3034QTX3034; QTX-3034Phase 1 ClinicalQuanta Therapeutics Inc
Neoplasms; Solid tumours
Details
ZoldonrasibRMC-9805; RM-036Phase 1 ClinicalRevolution Medicines Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Neoplasms; Solid tumours
Details
BEBT-607C200825009-FP; BEBT-607Phase 1 ClinicalGuangzhou BeBetter Medicine Technology Co
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours
Details
BI-1701963BI-1701963Phase 1 ClinicalForma Therapeutics Holdings Inc
Colorectal Neoplasms; Solid tumours
Details
Targeted KRAS TCR-T cell therapy(Immuxell Biotech)ClinicalShanghai Immuxell Biotech Ltd
Carcinoma, Pancreatic Ductal
Details
CWG-59rCWG-59r; CWG-59-r; CWG59rClinicalCellworks Group
Neoplasms
Details
CWG-71bCWG-71b; CWG-71-b; CWG71bClinicalCellworks Group
Neoplasms
Details
CWG-89CWG-89ClinicalCellworks Group
Neoplasms
Details
CWG-71a (Cellworks Group)CWG-71aClinicalCellworks Group Inc
Neoplasms
Details